Novartis says it overpaid Roche’s Genentech nearly $210M in a licensing deal—and it wants its money back

Novartis says it overpaid Roche’s Genentech nearly $210M in a licensing deal—and it wants its money back
nhigginsdunn
Mon, 06/28/2021 – 11:25